• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用指南研究与评价工具II(AGREE II)对胆管癌现行管理指南的评估

Appraisal of the current guidelines for management of cholangiocarcinoma-using the Appraisal of Guidelines Research and Evaluation II (AGREE II) Instrument.

作者信息

Gavriilidis Paschalis, Askari Alan, Roberts Keith J, Sutcliffe Robert P

机构信息

Department of Hepato-Pancreato-Biliary and Liver Transplant Surgery, Queen Elizabeth University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Department of Upper Gastro-Intestinal Surgery, West Hertfordshire Hospitals NHS Trust, Watford, UK.

出版信息

Hepatobiliary Surg Nutr. 2020 Apr;9(2):126-135. doi: 10.21037/hbsn.2019.09.06.

DOI:10.21037/hbsn.2019.09.06
PMID:32355672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7188526/
Abstract

Cholangiocarcinoma (CC) is the second most common primary liver tumour. High-quality guidelines are essential for effective patient stratification and individualised treatment. This study aimed to appraise the methodological quality of existing guidelines for the resection of CC using the Appraisal of Guidelines for Research & Evaluation (AGREE II) instrument. A systematic search of the literature in Cochrane, PubMed, Google Scholar, and Embase was performed. Assessment of the clinical practice guidelines (CPGs) and consensuses was performed using the AGREE II instrument by four clinicians experienced in surgical practice and the AGREE II appraisal method. Literature searches identified 13 guidelines of highly variable quality according to the AGREE II criteria. The guidelines scored well in certain domains such as scope & purpose (median score across all guidelines; 65%), clarity of presentation (76%), and editorial independence (56%). However, they scored poorly for applicability (13%), rigour of development (30%), and stakeholder involvement (39%). None of the 13 guidelines was recommended universally for use without modification. Overall, the methodological quality of guidelines on the surgical management of CC is poor. Future updates should address and modify shortcomings detected by the AGREE II instrument, thereby facilitating better patient stratification and individualised treatment strategies.

摘要

胆管癌(CC)是第二常见的原发性肝癌。高质量的指南对于有效的患者分层和个体化治疗至关重要。本研究旨在使用研究与评价指南(AGREE II)工具评估现有CC切除术指南的方法学质量。我们在Cochrane、PubMed、谷歌学术和Embase中对文献进行了系统检索。由四名具有外科实践经验的临床医生使用AGREE II工具和AGREE II评估方法对临床实践指南(CPG)和共识进行评估。文献检索发现了13项根据AGREE II标准质量差异很大的指南。这些指南在某些领域得分较高。如范围与目的(所有指南的中位数得分;65%)、表述清晰度(76%)和编辑独立性(56%)。然而,它们在适用性(13%)、制定的严谨性(30%)和利益相关者参与度(39%)方面得分较低。这13项指南中没有一项被普遍推荐不经修改即可使用。总体而言,CC手术管理指南的方法学质量较差。未来的更新应解决并修正AGREE II工具发现的不足之处,从而促进更好的患者分层和个体化治疗策略。

相似文献

1
Appraisal of the current guidelines for management of cholangiocarcinoma-using the Appraisal of Guidelines Research and Evaluation II (AGREE II) Instrument.使用指南研究与评价工具II(AGREE II)对胆管癌现行管理指南的评估
Hepatobiliary Surg Nutr. 2020 Apr;9(2):126-135. doi: 10.21037/hbsn.2019.09.06.
2
Evaluation of the current guidelines for resection of hepatocellular carcinoma using the Appraisal of Guidelines for Research and Evaluation II instrument.运用 AGREE II 工具评价肝细胞癌切除术的现行指南。
J Hepatol. 2017 Nov;67(5):991-998. doi: 10.1016/j.jhep.2017.06.028. Epub 2017 Jul 8.
3
Appraisal of the current guidelines for the management of diverticular disease using the Appraisal of Guidelines Research and Evaluation II (AGREE II) instrument.应用 AGREE II 工具评估目前的憩室疾病管理指南。
Ann R Coll Surg Engl. 2021 Jul;103(7):471-477. doi: 10.1308/rcsann.2021.0013. Epub 2021 Apr 14.
4
Are clinical practice guidelines for low back pain interventions of high quality and updated? A systematic review using the AGREE II instrument.关于腰痛干预措施的临床实践指南质量高且更新及时吗?一项使用AGREE II工具的系统评价。
BMC Health Serv Res. 2020 Oct 22;20(1):970. doi: 10.1186/s12913-020-05827-w.
5
A critical appraisal of urolithiasis clinical practice guidelines using the AGREE II instrument.使用AGREE II工具对尿石症临床实践指南进行的批判性评价。
Transl Androl Urol. 2023 Jun 30;12(6):977-988. doi: 10.21037/tau-22-846. Epub 2023 Jun 13.
6
Erectile dysfunction management: a critical appraisal of clinical practice guidelines with the AGREE II instrument.勃起功能障碍管理:应用 AGREE II 工具对临床实践指南的批判性评估。
Int J Impot Res. 2022 Aug;34(5):471-476. doi: 10.1038/s41443-021-00442-7. Epub 2021 May 3.
7
Clinical practice guidelines for the management of community-acquired pneumonia: A critical appraisal using the AGREE II instrument.社区获得性肺炎管理临床实践指南:应用 AGREE II 工具进行的批判性评价。
Int J Clin Pract. 2020 May;74(5):e13478. doi: 10.1111/ijcp.13478. Epub 2020 Feb 24.
8
Clinical practice guidelines for the treatment and management of low back pain: A systematic review of quantity and quality.临床实践指南:腰痛的治疗和管理,系统评价数量和质量。
Musculoskelet Sci Pract. 2021 Feb;51:102295. doi: 10.1016/j.msksp.2020.102295. Epub 2020 Nov 7.
9
Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II.度普利尤单抗获批后特应性皮炎的治疗指南:使用AGREE-II进行的系统评价和质量评估
Front Med (Lausanne). 2022 Mar 9;9:821871. doi: 10.3389/fmed.2022.821871. eCollection 2022.
10
A systematic review of paediatric neurogenic lower urinary tract dysfunction guidelines using the Appraisal of Guidelines and Research Evaluation (AGREE) II instrument.应用 AGREE II 工具对儿科神经源性下尿路功能障碍指南进行系统评价。
BJU Int. 2023 May;131(5):520-529. doi: 10.1111/bju.15902. Epub 2022 Oct 19.

引用本文的文献

1
An evidence map of clinical practice guideline recommendations and quality of non-pharmaceutical interventions for post-stroke emotional disorders.中风后情绪障碍的临床实践指南建议及非药物干预质量的证据图谱。
Front Neurol. 2025 Jun 9;16:1580799. doi: 10.3389/fneur.2025.1580799. eCollection 2025.
2
Summary of the best evidence for vocal rehabilitation training in adults with unilateral vocal fold paralysis.成人单侧声带麻痹嗓音康复训练的最佳证据总结
Ann Med Surg (Lond). 2024 Nov 13;86(12):7270-7277. doi: 10.1097/MS9.0000000000002722. eCollection 2024 Dec.
3
Clinical practice guidelines in adult diagnostic flexible bronchoscopy: systematic review of the literature and quality appraisal with AGREE II.成人诊断性可弯曲支气管镜检查临床实践指南:文献系统评价及AGREE II质量评估
J Thorac Dis. 2024 Oct 31;16(10):7111-7122. doi: 10.21037/jtd-24-773. Epub 2024 Oct 30.
4
Evidence-based summary of preventive care for central venous access device-related thrombosis in hospitalized children.住院儿童中心静脉通路装置相关血栓形成的预防性护理循证总结
BMC Nurs. 2024 Sep 18;23(1):664. doi: 10.1186/s12912-024-02294-0.
5
Summary of evidence on prevention and management of bladder dysfunction in patients after radical hysterectomy.根治性子宫切除术患者膀胱功能障碍预防和管理的证据总结。
Nurs Open. 2024 Jul;11(7):e2240. doi: 10.1002/nop2.2240.
6
Assessment of guidelines for bariatric and metabolic surgery: a systematic review and evaluation using appraisal of guidelines for research and evaluation II (AGREE II).评估减重和代谢手术指南:使用研究和评估指南评价 II(AGREE II)进行的系统评价和评估。
Int J Obes (Lond). 2024 Sep;48(9):1193-1204. doi: 10.1038/s41366-024-01559-7. Epub 2024 Jun 18.
7
National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma.国家肝门部胆管癌诊断和治疗指南。
World J Gastroenterol. 2024 Mar 7;30(9):1018-1042. doi: 10.3748/wjg.v30.i9.1018.
8
Limitations concerning evaluation of the current guidelines using the Appraisal of Guidelines Research and Evaluation II.使用《指南研究与评价Ⅱ》对现行指南进行评估时存在的局限性。
Ann Transl Med. 2023 Aug 30;11(10):373. doi: 10.21037/atm-2023-10. Epub 2023 Jun 26.
9
Evaluation of the current guidelines for the management of haemorrhoidal disease using the Appraisal of Guidelines Research and Evaluation II instrument.使用《指南研究与评价II》工具对痔病管理现行指南的评估
Ann Transl Med. 2023 Mar 31;11(6):265. doi: 10.21037/atm-22-4255. Epub 2023 Feb 16.
10
Systemic review of the robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survival time, and the spin effect.对随机对照试验在治疗胆管癌方面在三个领域的稳健性进行的系统评价:生存推断脆弱性指数、受限平均生存时间和自旋效应。
Hepatobiliary Surg Nutr. 2022 Dec;11(6):861-869. doi: 10.21037/hbsn-21-118.

本文引用的文献

1
Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma.外科治疗集中化趋势与国家癌症中心网络切除性胆管癌治疗指南的遵循情况。
HPB (Oxford). 2019 Aug;21(8):981-989. doi: 10.1016/j.hpb.2018.11.013. Epub 2018 Dec 25.
2
Evaluation of the current guidelines for resection of hepatocellular carcinoma using the Appraisal of Guidelines for Research and Evaluation II instrument.运用 AGREE II 工具评价肝细胞癌切除术的现行指南。
J Hepatol. 2017 Nov;67(5):991-998. doi: 10.1016/j.jhep.2017.06.028. Epub 2017 Jul 8.
3
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胆管癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v28-v37. doi: 10.1093/annonc/mdw324.
4
GRADE Methods for Guideline Development: Time to Evolve?《指南制定的GRADE方法:是时候发展了吗?》
Ann Intern Med. 2016 Dec 6;165(11):810-811. doi: 10.7326/M16-1254. Epub 2016 Sep 20.
5
GUIDELINE FOR THE MANAGEMENT OF BILE DUCT CANCERS BY THE BRAZILIAN GASTROINTESTINAL TUMOR GROUP.巴西胃肠道肿瘤小组胆管癌管理指南
Arq Gastroenterol. 2016 Jan-Mar;53(1):5-9. doi: 10.1590/S0004-28032016000100003.
6
Biliary tract cancers: SEOM clinical guidelines.胆道癌:SEOM临床指南。
Clin Transl Oncol. 2015 Dec;17(12):982-7. doi: 10.1007/s12094-015-1436-2. Epub 2015 Nov 25.
7
Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review.可切除性肝门周围胆管癌的淋巴结清扫:一项系统评价
Am J Surg. 2015 Oct;210(4):694-701. doi: 10.1016/j.amjsurg.2015.05.015. Epub 2015 Jun 29.
8
Hilar cholangiocarcinoma: expert consensus statement.肝门部胆管癌:专家共识声明
HPB (Oxford). 2015 Aug;17(8):691-9. doi: 10.1111/hpb.12450.
9
Intrahepatic cholangiocarcinoma: expert consensus statement.肝内胆管癌:专家共识声明
HPB (Oxford). 2015 Aug;17(8):669-80. doi: 10.1111/hpb.12441.
10
Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review.肝细胞癌和肝内胆管癌切除术中淋巴结的管理:一项系统评价
J Gastrointest Surg. 2014 Dec;18(12):2136-48. doi: 10.1007/s11605-014-2667-1. Epub 2014 Oct 10.